Auristatin F(CAS: 163768-50-1)

CAS Number
Related Products
[4-(Propoxymethyl)phenyl]boronic acid
CAS Number: 160061-48-3
4-Hydroxy-8-methyl-2-propylquinoline
CAS Number: 1070879-87-6
Other Suppliers for Auristatin F
Basic Information
Molecular Formula
C40H67N5O8
Molecular Weight
745.99 g/mol
Physical State
White to Off-White
Physical Properties
Melting Point
>140°C (dec.)
Boiling Point
894.4±65.0 °C(Predicted)
Density
1.112±0.06 g/cm3(Predicted)
Chemical Identifiers
SMILES
CC[C@@H]([C@H](N(C(=O)[C@H](C(C)C)NC(=O)[C@@H](N(C)C)C(C)C)C)[C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)C)OC)OC)C
InChIKey
LGNCNVVZCUVPOT-FUVGGWJZSA-N
Database References
MDL Number
MFCD25976745
FAQ
Auristatin F (CAS: 163768-50-1) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS). In the European Union, it falls under the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulations. In the USA, it is regulated by the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) for drug development and manufacturing purposes. Specific handling, storage, and disposal guidelines should be followed based on these regulations.
There are several alternatives to Auristatin F (CAS: 163768-50-1) in synthesis, including auristatin E and auristatin P. These analogs offer similar therapeutic properties and can be used as substitutes in various drug development processes. Common alternative reagents used in synthesis include various amino acids and linker compounds, depending on the specific requirements of the chemical structure being synthesized.
The market for Auristatin F (CAS: 163768-50-1) is driven by its use in cancer treatment, particularly in the development of antibody-drug conjugates (ADCs). Research trends are focusing on improving the efficacy and reducing side effects of ADCs containing Auristatin F. Additionally, there is increasing interest in optimizing the synthesis and delivery methods of Auristatin F-based therapeutics, driven by advancements in medicinal chemistry and biotechnology.
Waste containing Auristatin F (CAS: 163768-50-1) should be managed according to environmental and safety regulations. Proper waste collection and disposal methods should be employed, such as using appropriate containers and ensuring the liquid is neutralized before disposal. Incineration is a common method for disposing of this waste, and professional waste disposal services should be utilized to ensure compliance with regulatory requirements. Environmental protection precautions, including the use of personal protective equipment and proper labeling, should be observed during handling and disposal.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Tang Silei
2881489226@qq.com
Mobile
15026964105
Telephone
15026964105
Fax
021-55068248
Visit Website
https://www.shyuanye.comAddress
No. 6 Building, 465 Changta Road, Songjiang District, Shanghai








![[4-(Propoxymethyl)phenyl]boronic acid](https://static.chemtradehub.com/structs/160/160061-48-3-d8f7.webp)



